Bausch Health Companies Inc. or Xencor, Inc.: Who Leads in Yearly Revenue?

Bausch Health vs. Xencor: A Revenue Showdown

In the competitive landscape of the pharmaceutical industry, Bausch Health Companies Inc. and Xencor, Inc. have carved distinct paths. From 2014 to 2023, Bausch Health consistently outperformed Xencor in annual revenue, with figures peaking in 2015 at approximately $10.5 billion. In contrast, Xencor's revenue, while growing, reached its highest in 2021 at around $275 million. This stark difference highlights Bausch Health's dominance, with revenues often exceeding Xencor's by over 9,000%. However, Xencor's growth trajectory is noteworthy, with a significant increase from 2014's $9.5 million to 2023's $168 million, marking a growth of over 1,600%. As the industry evolves, these companies' strategies will be crucial in shaping their future revenue streams.